1,673 material Form 8-K filings that 1,260 companies we cover made with the SEC in February 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Dr. Julian Kenyon retired from the Board of Directors of Propanc Biopharma, Inc. effective February 20, 2026, to focus on his personal and family life, and will remain a medical advisor to the company. The same day, the Board filled the vacancy by appointing Dr. Ralf Brant, a pharmaceutical and oncology research executive, to serve until his removal or resignation.
Dr. Julian Kenyon retired and stepped down from the Board effective February 20, 2026, and will remain a medical advisor to the company.
Dr. Ralf Brant was appointed to the Board on February 20, 2026, to fill the vacancy.
The filing describes Dr. Brant as having over thirty years of experience in drug discovery and oncology, and as a serving member of scientific advisory boards including Propanc Biopharma.
Exhibit 10.1, a Director Agreement dated February 20, 2026, is filed with the report; the exhibit names the director as Dr. Ralf Brandt.
NewMarket Corporation's board elected Bruce R. Hazelgrove, III, the company's Executive Vice President and Chief Administrative Officer, as a director on February 26, 2026, effective immediately. He will not receive extra compensation for board service and will sit on the Executive Committee, but not on other board committees because he is not independent as a company officer.
Board election effective February 26, 2026; Hazelgrove is currently Executive Vice President and Chief Administrative Officer
No additional compensation for his board service
Will serve on the Executive Committee; not independent, so no other board committees
Related-party information is incorporated by reference from the March 12, 2025 proxy statement
Federal Signal's board increased its size from seven to nine directors and appointed Richard A. Maue, CFO of Crane Company, and Eric A. Vaillancourt, CEO of Enpro Inc., effective February 26, 2026. The filing describes the appointments as board additions with standard director compensation and no financial results, so they carry no direct financial figures for shareholders.
Board expanded from seven to nine directors on February 26, 2026.
Richard A. Maue joins the Audit Committee; he has been CFO of Crane Company since January 2013.
Eric A. Vaillancourt joins the Compensation and Benefits Committee; he has been CEO of Enpro Inc. since November 28, 2021.
Each new director receives a $90,000 annual base retainer and a $145,000 annual equity award beginning in 2026.
On February 25, 2026, CBRE's Compensation Committee issued a one-time retention award with a $5.0 million total target grant value to Vikram Kohli, the company's Chief Operating Officer and Chief Executive Officer, Advisory Services. The award consists entirely of performance RSUs that vest only if relative TSR or relative EPS goals are met over five-year periods, and it is also contingent on Kohli remaining employed for the full five-year vesting period.
Total target grant value of $5.0 million, split equally between relative TSR and relative EPS performance RSUs
Payouts range from 0% to 175% of target, with no vesting unless performance exceeds the 40th percentile of S&P 500 companies as of February 25, 2026
rTSR measurement period runs from February 25, 2026 to January 31, 2031; rEPS period runs from January 1, 2026 to December 31, 2030
Vesting term of five years is longer than the three-year vesting period for CBRE's annual Performance RSU awards
AMG announced that G. Staley Cates, former Vice Chairman of Southeastern Asset Management, will join its Board as an independent director effective April 1, 2026. Director Karen L. Alvingham, who joined the Board in January 2018, will retire from the Board on the same date, and Jay C. Horgen was re-appointed President effective April 1, 2026 while continuing as Chief Executive Officer. The filing contains no financial results, so the changes affect board composition and leadership titles rather than reported performance.
G. Staley Cates joins the Board as an independent director effective April 1, 2026; he was Vice Chairman of Southeastern from 2015 through 2024 and its President from 1989 through 2015.
Karen L. Alvingham will retire from the Board effective April 1, 2026; she was appointed in January 2018.
Jay C. Horgen was re-appointed President effective April 1, 2026 and will continue to serve as Chief Executive Officer.
Rexford Industrial Realty appointed John Nahas as Chief Operating Officer effective April 1, 2026, alongside Laura Clark's previously announced move to Chief Executive Officer. The company also adopted an Executive Severance Plan and said it reaffirmed its 2026 general and administrative expense guidance of approximately $60 million.
Nahas, age 43, joined the company in January 2023 and has been Managing Director of Operations and Asset Management since July 2023.
The company reaffirmed its previously disclosed 2026 general and administrative expense guidance of approximately $60 million.
The press release says total aggregate executive compensation was significantly reduced by approximately 50% compared with prior levels.
The Executive Severance Plan is effective February 24, 2026; Co-CEOs Michael S. Frankel and Howard Schwimmer are excluded from it.
J.M. Smucker's board increased its size to 11 members and elected Woo-Sung (Bruce) Chung, CFO of NRG Energy, and David Singer, former CEO of Snyder's-Lance, effective April 15, 2026. The appointments follow engagement with Elliott Investment Management, and the company has entered an information-sharing agreement with Elliott. The filing reports no financial results, so the change is a governance development rather than a direct financial measure.
Board expanded to 11 directors, with 10 described as independent, effective April 15, 2026
Chung and Singer will both serve on the Audit Committee; Mercedes Abramo moves from Audit to Nominating, Governance, and Corporate Responsibility Committee
Appointments follow constructive engagement with Elliott Investment Management, which the company describes as one of its largest investors
Company will enter indemnity agreements with Chung and Singer, in substantially the same form as those with current directors
Dexcom's board increased its size to twelve directors and appointed Albert F. ("Rick") Osterloh IV, Senior Vice President, Platforms & Devices at Google, as a director effective February 26, 2026. He joins the Compensation and Technology Committees, and the filing describes him as independent under Nasdaq listing standards.
Osterloh's term expires at the 2026 annual stockholder meeting.
Initial equity grant of restricted stock units with a fair value of $500,000, vesting annually over three years.
Expected annual director equity grant of restricted stock units with a fair value of $101,027, prorated from a $325,000 base award.
Parsons' board approved a stock award for CEO Carey A. Smith on February 20, 2026, with a target grant-date value of $10 million, split 60% performance stock units and 40% restricted stock units. The award is meant to recognize her performance and retain her, and its performance units pay out based on the company's relative total stockholder return against a custom peer group, so pay depends on how the stock performs against peers.
Board approved the award on February 20, 2026, with a target grant-date value of $10 million.
PSUs (60%) cover January 1, 2026 through December 31, 2029; target payout is $6 million at the 65th percentile of relative TSR.
RSUs (40%) vest ratably over four years starting March 10, 2026, about $1 million per year at target.
PSU payout is zero at or below the 35th percentile and capped at $9 million (150% of target) at or above the 75th percentile.
Elevance Health announced management changes: CFO Mark Kaye will add oversight of Carelon, and Felicia Norwood will lead a consolidated Health Benefits organization. Carelon president Peter D. Haytaian leaves that role effective May 4, 2026, and will serve as Special Advisor through December 31, 2026. The company also reaffirmed its 2026 earnings and benefit expense ratio guidance, so the leadership changes come without a change to its outlook.
Peter D. Haytaian leaves his role as President of Carelon effective May 4, 2026, to devote more time to family commitments; he will serve as Special Advisor through December 31, 2026.
CFO Mark Kaye expands his responsibilities to include oversight of Carelon; Felicia Norwood assumes responsibility for the consolidated Health Benefits organization.
2026 guidance reaffirmed: shareholders' earnings of at least $22.30 per diluted share, including about $3.20 per diluted share of net unfavorable items; adjusted earnings of at least $25.50 per diluted share.
Benefit expense ratio guidance for 2026 reaffirmed at 90.2% plus or minus 50 basis points.
Kilroy Realty's board appointed Gary Stevenson as Chair effective February 24, 2026, succeeding Edward Brennan, who remains a director. The board also expanded from seven to nine members with two new independent directors, and director Peter Stoneberg will retire at the 2026 annual meeting. The changes affect board leadership and committee oversight, and the filing reports no financial results.
Gary Stevenson appointed Chair of the Board effective February 24, 2026, succeeding Edward Brennan, PhD
Cia Buckley Marakovits and David Kieske appointed independent directors; board size increased from seven to nine
Peter Stoneberg will not stand for re-election and will retire at the 2026 annual meeting; board to decrease to eight
Corporate Social Responsibility and Sustainability Committee to be disbanded; Brennan named Audit Committee chair and Jolie Hunt named Executive Compensation Committee chair
Chief Financial Officer Carey Hendrickson will leave U.S. Physical Therapy on April 24, 2026 to take another CFO job at a publicly traded company, and the company says the decision was not tied to any disagreement about accounting or financial reporting. Senior Vice President of Finance and Accounting Jason Curtis will serve as interim CFO during a search for a permanent successor. The same filing reports fourth-quarter results in which adjusted EBITDA rose 13.5% while GAAP net income attributable to USPH shareholders fell to $4.2 million from $9.2 million.
Hendrickson's last day is April 24, 2026; Jason Curtis becomes interim CFO while the company searches for a permanent successor.
Q4 2025 Non-GAAP Adjusted EBITDA was $24.8 million, up 13.5% from $21.8 million; USPH net income was $4.2 million versus $9.2 million, mainly due to a $5.2 million net loss from contingent earnout consideration.
Q4 2025 loss per share was $0.44 versus earnings per share of $0.52 a year earlier.
2026 Adjusted EBITDA guidance is $102.0 million to $106.0 million; quarterly dividend raised to $0.46 per share from $0.45, payable April 10, 2026.
Manhattan Associates said CFO Dennis Story will retire as Executive Vice President, Chief Financial Officer, and Treasurer effective March 31, 2026, and will serve as advisor to the CEO through December 31, 2026. Linda Pinne, the company's Senior Vice President, Global Corporate Controller, and Chief Accounting Officer since January 2016, will succeed him, and the company reaffirmed its 2026 financial guidance.
Dennis Story has served as CFO since March 2006; his retirement takes effect at the close of business on March 31, 2026.
Linda Pinne will hold the titles of Senior Vice President, Chief Financial Officer, Chief Accounting Officer, and Treasurer.
Story's retirement agreement continues his $512,000 base salary while he serves as advisor, and his unvested RSUs vest on December 31, 2026.
The company reaffirmed its 2026 financial guidance provided on January 27, 2026.
Cognizant disclosed that on February 23, 2026, Balu Ganesh Ayyar moved from his role as President of Intuitive Operations and Automation and Industry Solutions to become President of Asia Pacific & Japan and Industry Solutions Group. The filing is an internal officer reassignment and does not include financial results or other financial figures.
Effective date of the change: February 23, 2026
Balu Ganesh Ayyar's prior role: President - Intuitive Operations and Automation and Industry Solutions
New role: President – Asia Pacific & Japan and Industry Solutions Group
Filing signed by John Kim, Chief Legal Officer, Chief Administrative Officer and Corporate Secretary, dated February 26, 2026
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.